2024 annual financial data

Forte Biosciences, Inc. 2024 Operating margin

Forte Biosciences, Inc. 2024 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -36,602,000 USD and net income was -35,478,000 USD.
Operating cash flow was -30,745,000 USD.

Get free Forte Biosciences, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-36,602,000 USD
Net income
-35,478,000 USD
Operating cash flow
-30,745,000 USD